118 related articles for article (PubMed ID: 32002826)
1. Spiroxatrine derivatives towards 5-HT
Sorbi C; Tait A; Battisti UM; Brasili L
Pharmacol Rep; 2020 Apr; 72(2):427-434. PubMed ID: 32002826
[TBL] [Abstract][Full Text] [Related]
2. Actions of alpha2 adrenoceptor ligands at alpha2A and 5-HT1A receptors: the antagonist, atipamezole, and the agonist, dexmedetomidine, are highly selective for alpha2A adrenoceptors.
Newman-Tancredi A; Nicolas JP; Audinot V; Gavaudan S; Verrièle L; Touzard M; Chaput C; Richard N; Millan MJ
Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):197-206. PubMed ID: 9750005
[TBL] [Abstract][Full Text] [Related]
3. Involvement of the first transmembrane segment of human α(2) -adrenoceptors in the subtype-selective binding of chlorpromazine, spiperone and spiroxatrine.
Laurila JM; Wissel G; Xhaard H; Ruuskanen JO; Johnson MS; Scheinin M
Br J Pharmacol; 2011 Nov; 164(5):1558-72. PubMed ID: 21649638
[TBL] [Abstract][Full Text] [Related]
4. [3H]spiroxatrine: a 5-HT1A radioligand with agonist binding properties.
Herrick-Davis K; Titeler M
J Neurochem; 1988 Feb; 50(2):528-33. PubMed ID: 2961850
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and 5-HT1A/5-HT2A receptor activity of new N-[3-(4-phenylpiperazin-1-yl)-propyl] derivatives of 3-spiro-cyclohexanepyrrolidine-2,5-dione and 3-spiro-beta-tetralonepyrrolidine-2,5-dione.
Obniska J; Pawłowski M; Kołaczkowski M; Czopek A; Duszyńska B; Klodzińska A; Tatarczyńska E; Chojnacka-Wójcik E
Pol J Pharmacol; 2003; 55(4):553-7. PubMed ID: 14581713
[TBL] [Abstract][Full Text] [Related]
6. [The alpha-antiadrenergic properties of spiroxatrine, a ligand of serotonergic 5-HT1A receptors].
Terrón JA; Ibarra M; Ransanz V; Hong E; Villalón CM
Arch Inst Cardiol Mex; 1993; 63(4):289-95. PubMed ID: 8105762
[TBL] [Abstract][Full Text] [Related]
7. [3H]spiroxatrine labels a serotonin1A-like site in the rat hippocampus.
Nelson DL; Monroe PJ; Lambert G; Yamamura HI
Life Sci; 1987 Sep; 41(13):1567-76. PubMed ID: 2957559
[TBL] [Abstract][Full Text] [Related]
8. Serotonergic properties of spiroxatrine enantiomers.
Nikam SS; Martin AR; Nelson DL
J Med Chem; 1988 Oct; 31(10):1965-8. PubMed ID: 2902227
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and Structure-Activity Relationships of Triazaspirodecanone Derivatives as Nociceptin/Orphanin FQ Receptor Ligands.
Corrado S; Battisti UM; Sorbi C; Tait A; Malfacini D; Camarda V; Calò G; Brasili L
Chem Biol Drug Des; 2015 Oct; 86(4):447-58. PubMed ID: 25546401
[TBL] [Abstract][Full Text] [Related]
10. Different roles of alpha2-adrenoceptor subtypes in non-pregnant and late-pregnant uterine contractility in vitro in the rat.
Gáspár R; Gál A; Gálik M; Ducza E; Minorics R; Kolarovszki-Sipiczki Z; Klukovits A; Falkay G
Neurochem Int; 2007 Oct; 51(5):311-8. PubMed ID: 17664026
[TBL] [Abstract][Full Text] [Related]
11. The replacement of the 2-methoxy substituent of N-((6,6-diphenyl-1,4-dioxan-2-yl)methyl)-2-(2-methoxyphenoxy)ethan-1-amine improves the selectivity for 5-HT
Del Bello F; Bonifazi A; Giannella M; Giorgioni G; Piergentili A; Petrelli R; Cifani C; Micioni Di Bonaventura MV; Keck TM; Mazzolari A; Vistoli G; Cilia A; Poggesi E; Matucci R; Quaglia W
Eur J Med Chem; 2017 Jan; 125():233-244. PubMed ID: 27662034
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.
Leonardi A; Barlocco D; Montesano F; Cignarella G; Motta G; Testa R; Poggesi E; Seeber M; De Benedetti PG; Fanelli F
J Med Chem; 2004 Apr; 47(8):1900-18. PubMed ID: 15055991
[TBL] [Abstract][Full Text] [Related]
13. Behavioral and neurochemical effects of the serotonin (5-HT)1A receptor ligand spiroxatrine.
Barrett JE; Hoffmann SM; Olmstead SN; Foust MJ; Harrod C; Weissman BA
Psychopharmacology (Berl); 1989; 97(3):319-25. PubMed ID: 2524083
[TBL] [Abstract][Full Text] [Related]
14. Analysis of ligand activation of alpha 2-adrenoceptor subtypes under conditions of equal G alpha protein stoichiometry.
Pauwels PJ; Wurch T; Tardif S; Finana F; Colpaert FC
Naunyn Schmiedebergs Arch Pharmacol; 2001 May; 363(5):526-36. PubMed ID: 11383713
[TBL] [Abstract][Full Text] [Related]
15. 5-HT1A receptor pharmacophores to screen for off-target activity of α1-adrenoceptor antagonists.
Ngo T; Nicholas TJ; Chen J; Finch AM; Griffith R
J Comput Aided Mol Des; 2013 Apr; 27(4):305-19. PubMed ID: 23625023
[TBL] [Abstract][Full Text] [Related]
16. The C-terminal half of the α2C-adrenoceptor determines the receptor's membrane expression level and drug selectivity.
Jahnsen JA; Uhlén S
Naunyn Schmiedebergs Arch Pharmacol; 2013 Dec; 386(12):1031-40. PubMed ID: 23868076
[TBL] [Abstract][Full Text] [Related]
17. A new, simple and robust radioligand binding method used to determine kinetic off-rate constants for unlabeled ligands. Application at α2A- and α2C-adrenoceptors.
Uhlén S; Schiöth HB; Jahnsen JA
Eur J Pharmacol; 2016 Oct; 788():113-121. PubMed ID: 27318322
[TBL] [Abstract][Full Text] [Related]
18. Actions of the prototypical 5-HT1A receptor agonist 8-OH-DPAT at human alpha2-adrenoceptors: (+)8-OH-DPAT, but not (-)8-OH-DPAT is an alpha2B subtype preferential agonist.
Heusler P; Rauly-Lestienne I; Tourette A; Tardif S; Ailhaud MC; Croville G; Cussac D
Eur J Pharmacol; 2010 Aug; 640(1-3):8-14. PubMed ID: 20450907
[TBL] [Abstract][Full Text] [Related]
19. [[(Arylpiperazinyl)alkyl]thio]thieno[2,3-d]pyrimidinone derivatives as high-affinity, selective 5-HT1A receptor ligands.
Modica M; Santagati M; Russo F; Parotti L; De Gioia L; Selvaggini C; Salmona M; Mennini T
J Med Chem; 1997 Feb; 40(4):574-85. PubMed ID: 9046348
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization of alpha 2-adrenoceptor-mediated responses in pig nasal mucosa.
Corboz MR; Varty LM; Rizzo CA; Mutter JC; Rivelli MA; Wan Y; Umland S; Qiu H; Jakway J; McCormick KD; Berlin M; Hey JA
Auton Autacoid Pharmacol; 2003 Aug; 23(4):208-19. PubMed ID: 15084187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
